Srinivas Akkaraju Mineralys Therapeutics, Inc. (MLYS) insider trading activity

MLYS Quotes by TradingView

SRINIVAS AKKARAJU Transaction History

Date Transaction Value Shares Traded Form
Feb 12 2024
BUY
Grant, award, or other acquisition
$7,499,992 $13.5 p/Share
555,555
Feb 14 2023
BUY
Conversion of derivative security
-
3,581,861
Feb 14 2023
BUY
Open market or private purchase
$15,000,000 $16.0 p/Share
937,500

Also insider at

KDNY
CHINOOK THERAPEUTICS, INC. Healthcare
Director
JYAC
Jiya Acquisition Corp. Financial Services
Director
SYRS
Syros Pharmaceuticals, Inc. Healthcare
ICPT
INTERCEPT PHARMACEUTICALS, INC. Healthcare
Director
VTVT
vTv Therapeutics Inc. Healthcare
SRRK
Scholar Rock Holding Corp Healthcare
ALMS
ALUMIS INC.
SA

Srinivas Akkaraju

Director
Cambridge, MA

Track Institutional and Insider Activities on MLYS

Follow Mineralys Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MLYS shares.

Notify only if

Insider Trading

Get notified when an Mineralys Therapeutics, Inc. insider buys or sells MLYS shares.

Notify only if

News

Receive news related to Mineralys Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MLYS